The Florida Department of Health has issued a statewide mosquito-borne illness advisory after four locally contracted cases of malaria were reported along the Gulf Coast south of Tampa.
The four residents in Sarasota County received treatment and have recovered, according to the state's Department of Health advisory. Malaria, caused by a parasite that spreads through bites from Anopheles mosquitoes, causes fever, chills, sweats, nausea and vomiting, and headaches. It is not spread person to person.
It's the threat of the mosquito-borne illness that concerns Kathleen Gibson-Dee, who lives on Terra Ceia Island, which is about 20 miles (32 kilometers) north of Sarasota County.
Even though no malaria cases have been reported in Manatee County, where Terra Ceia is located, Gibson-Dee said that she's now routinely using bug repellent while working in her garden.
“I don’t go out without it,” she told The Associated Press on Tuesday. “And we don't go out in the evening because you can see clouds and clouds of bugs now. They may not all be mosquitoes, but there’s certainly mosquitos out there.”
Another resident, Tom Lyons, says news of the malaria cases “makes me take mosquito protection a little more seriously."
The mosquito population thrives in Terra Ceia because "it's an island surrounded by a lot of shallow water and mangroves, and ideal places for mosquitoes,” Lyons said.
Officials in Manatee County have ramped up efforts to control the mosquito population.
Chris Lesser, director of the Manatee County mosquito control district, said they're primarily using helicopters to combat the mosquito population because they cover between 15,000 and 20,000 acres (6070 to 8082 hectares) in one night. A truck can only cover around 1,000 acres (404 hectares) a night, he said.
“We really want to focus on killing the adult mosquito before they have the opportunity to feed on one person that may be infected with malaria and then transmit that disease to a second person,” Lesser said.
He said the time frame for when a mosquito can become infected to when it can transmit the disease to a person is about 14 days.
“So we’re trying to get in there about once every seven to 10 days and really knock down the mosquito population. And that process will continue until the public health alert that we’re currently under is lifted,” Lesser said.
“It's a curtain,” he continued. “We're trying to keep the malaria mosquitos from coming into our county through our southern border by using aggressive mosquito control activities.”
Officials in Sarasota County area also using similar tactics to control mosquitos, the county's health department said in an advisory.
The initial malaria advisory was issued in Sarasota County after the first case was reported in late May. That was followed by a second case, and then two more, said Jae Williams, the press secretary for the Florida Department of Health.
“As soon as it crossed over from one to two confirmed cases, it progressed to an alert,” Williams said, comparing it to the system of issuing a hurricane watch versus a hurricane warning — when a storm is imminent.
“Listen, the conditions are favorable," Williams continued. "It's not just some rogue one mosquito. People need to be paying attention.”
Williams said health officials are being proactive.
“We know we are going into the Fourth of July holiday. We know the summer’s only getting hotter and wetter over the next couple of months,” Williams said. “So we just wanted to give Floridians a big kind of heads up, put the whole state on notice.”
About 2,000 U.S. cases of malaria are diagnosed each year — the vast majority in travelers coming from countries where malaria commonly spreads.
Since 1992, there have been 11 outbreaks involving malaria from mosquitoes in the U.S. The last one occurred in 2003 in Palm Beach County, Florida, where eight cases were reported.
Healthcare workforce management platform ShiftMed
recently announced a $45 million funding round.
The company's platform connects nurses and healthcare professionals to hospitals and other healthcare providers.
ShiftMed's new funding comes amid widespread labor shortages in the healthcare sector. The company's CEO Todd Walrath joins Cheddar News' Closing Bell to discuss.
Universities like UCLA, Yale, and Duke have announced they're implementing remote learning amid the COVID omicron variant surge, despite President Biden recommending that K-12 schools should continue in-person education. Jared C. Bass, senior director for Higher Education at American Progress, joined Cheddar to break down what institutions of higher education might be considering differently. "I think some universities are allowing periods of a bit of a respite to allow students to get testing and make sure when they do return back to campus that they're healthy," he noted.
Supply chain issues have become one of the biggest roadblocks for the U.S. EV market, with production woes likely to stunt the industry's growth in 2022. Rich Steinberg, electric vehicle expert and industry advisor, told Cheddar that the Biden administration investing in domestic mining for essential minerals used in battery manufacturing — such as lithium — could help alleviate the bottlenecks. "Some of those same materials are available domestically, they just haven't been prioritized," he said, noting the paradox between green tech and "dirty" mining. "The good news is that there are ways to extract those materials cleanly."
Hyperfine, the pioneer of the very first FDA-approved portable MRI device, made its public debut on the Nasdaq via a SPAC merger. CEO Dave Scott joined Cheddar's "Opening Bell" to discuss the IPO launch, the company's valuation at $580 million, and the impact of its machine called Swoop. "We can roll an MRI system, our MRI Swoop system, right into the room where you are, right up to your patient bedside, and scan you right there and get an image in less than an hour," he explained.
Dr. Rob Davidson, Executive Director of the Committee to Protect Health Care and an ER Physician in West Michigan, joins Cheddar News to break down the expectations of Pfizer's new COVID-19 treatment pill.
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
